Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

Featuring an interview with Dr Rafael Fonseca, including the following topics:

• Safe management of bispecific antibodies and chimeric antigen receptor (CAR) T-cell therapy for patients with multiple myeloma (MM) (0:00)
• Sequencing bispecific antibodies and CAR T-cell therapy (10:40)
• Available data with and potential future clinical integration of belantamab mafodotin in the management of MM (16:03)
• Optimizing maintenance therapy for patients with MM (31:11)
• Novel management strategies for smoldering myeloma (36:29)
• Role of anti-CD38 antibodies in the up-front management of MM (41:41)
• Available data with cereblon E3 ligase modulatory drugs for MM (47:45)

CME information and select publications